The peptide's presence in nearly every cell type hints at its fundamental biological importance
Regulatory watch Last reviewed Jul 1, 2026 Next review Jul 29, 2026 Evidence snapshot AOD-9604 was developed by Metabolic Pharmaceuticals (Australia) as a modified C-terminal fragment (residues 177-191) of human growth hormone, designed to retain lipolytic activity without growth-promoting effects
This metabolic boost can also improve energy levels, reduce fatigue, and support other health improvements, making it a comprehensive tool for those looking to transform their body and their health
From vitamin D to MIC blends, our formulations are designed to support immunity and total-body balance
This is particularly problematic for symmetric complexes, where flexibility within individual subunits can be difficult to resolve (Suder and Gonen, 2024)